Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Devices

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.

Revenue projections:

Revenue projections for STE
Revenue projections for STE

With STE's revenues forecasted to be lower than last year's, investors are expected to be cautious. A decline in revenue typically harms the company's bottom line, reducing profitability and making investors less confident about the company's ability to sustain its financial health.

Financial Ratios:

currentRatio 1.906000
forwardPE 18.975088
debtToEquity 28.312000
earningsGrowth 0.140000
revenueGrowth 0.073000
grossMargins 0.444220
operatingMargins 0.191530
trailingEps 8.180000
forwardEps 12.247110

STERIS plc's current ratio is 1.906, showing the company's capacity to service its short-term debt through its cash reserves and current assets. This is a positive indicator of liquidity, suggesting STERIS plc has no trouble covering its short-term financial obligations.
STE's Forward PE ratio suggests that the stock is priced appropriately in relation to its earnings. Not being overpriced, it offers room for growth, signaling potential upside for investors looking for a stock with reasonable valuation and growth potential.
STE's low Debt-to-Equity ratio indicates the company is not over-leveraged. This suggests a balanced financial structure with limited reliance on debt, which reduces financial risk and enhances its stability, making STE's financial position more secure and appealing to investors.
STERIS plc's forward EPS being higher than its trailing EPS points to expected growth in profitability. This suggests that the company is projected to perform better in the current financial year, with higher earnings forecasted compared to the previous year.

Price projections:

Price projections for STE
Price projections for STE

Over time, price projections for STE have been gradually revised upward, reflecting increasing optimism about the company's future performance. This trend suggests analysts are growing more confident in STE's ability to deliver strong results and achieve higher market value.

Insider Transactions:

Insider Transactions for STE
Insider Transactions for STE


12 transactions were made to sell STE shares, with market price of 238.55500030517578.There were no sell transactions throughout the period under consideration.The higher volume of buys compared to sells near current STERIS plc price levels may suggest optimism among investors. This could point to a favorable market outlook, as more people are willing to invest at these prices, anticipating potential future growth or strong performance.

Recommendation changes over time:

Recommendations trend for STE
Recommendations trend for STE


Recent analysis shows a strong buy bias for STE, encouraging investors to view it as a solid investment option. The positive sentiment surrounding STE suggests it could be an attractive place to allocate funds, motivating potential investors to consider the stock as a valuable part of their portfolio.